BRTX
BioRestorative Therapies Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.30
-0.01 ▼ -1.66%
🌙 3월 13일 7:53 PM ET (한국 3/14 08:53)
$0.30
-0.01 ▼ -2.51%
| Index | - | P/E | - | EPS (ttm) | -1.51 | Insider Own | 34.81% | Shs Outstand | 0.02B | Perf Week | 42.27% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 53.99% | Insider Trans | - | Shs Float | 0.01B | Perf Month | -26.59% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -0.37 | Inst Own | 5.24% | Short Float | 5.59% | Perf Quarter | -72.46% |
| Income | -0.01B | P/S | 17.21 | EPS this Y | -40.52% | Inst Trans | 11.81% | Short Ratio | 0.09 | Perf Half Y | -81.07% |
| Sales | 0.00B | P/B | 1.1 | EPS next 5Y | 18.41% | ROA | -125.35% | Short Interest | 0.79M | Perf YTD | -74.22% |
| Book/sh | 0.27 | P/C | 1.46 | EPS past 3/5Y | 68.58% 78.69% | ROE | -207.73% | 52W High | -85.58% ($2.10) | Perf Year | -81.3% |
| Cash/sh | 0.21 | P/FCF | - | Sales past 3/5Y | 105.81% 25.27% | ROIC | -574.11% | 52W Low | 59.42% ($0.19) | Perf 3Y | -90.23% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -111.67% | Gross Margin | 39.21% | Volatility(W/M) | 19.77% 16.81% | Perf 5Y | -99.42% |
| Dividend TTM | - | EV/Sales | 5.42 | Sales Y/Y TTM | 1.7% | Oper. Margin | -3785.07% | ATR (14) | 0.06 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 1.37 | EPS Q/Q | -147.99% | Profit Margin | -3304.77% | RSI (14) | 35.89 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.37 | Sales Q/Q | -94.95% | SMA20 | 22.92% ($0.24) | Beta | 0.26 | Target Price | $9.5 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -59.02% ($0.73) | Rel Volume | 0.28 | Prev Close | $0.31 |
| Employees | 11 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 8.33% -97.43% | SMA200 | -76.69% ($1.29) | Avg Volume(3M) | 8.83M | Price | $0.3 |
| IPO | 1999/6/28 | Option/Short | No/Yes | Trades | 1825 | Volume | 2,472,180 | Change | -1.66% |
뉴스 로딩 중...